Intervention Review

Methotrexate for multiple sclerosis

  1. Orla Gray1,*,
  2. Gavin V McDonnell1,
  3. Raeburn B Forbes2

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group

Published Online: 19 APR 2004

Assessed as up-to-date: 9 OCT 2007

DOI: 10.1002/14651858.CD003208.pub2

How to Cite

Gray O, McDonnell GV, Forbes RB. Methotrexate for multiple sclerosis. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003208. DOI: 10.1002/14651858.CD003208.pub2.

Author Information

  1. 1

    Royal Victoria Hospital, Department of Neurology, Belfast, Northern Ireland, UK

  2. 2

    Craigavon Area Hospital, Portadown, County Armagh, UK

*Orla Gray, Department of Neurology, Royal Victoria Hospital, Grosvenor Road, Belfast, Northern Ireland, BT12 6BA, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004


  1. Current Version

    Methotrexate for multiple sclerosis

    Orla Gray, Gavin V McDonnell and Raeburn B Forbes

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD003208.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Methotrexate for multiple sclerosis

    O Gray, GV McDonnell and RB Forbes

    Article first published online: 27 JUN 2000 | DOI: 10.1002/14651858.CD003208